Period Ending |
Dec 31, 2014 |
Sep 30, 2014 |
Jun 30, 2014 |
Mar 31, 2014 |
Total Revenue |
– |
– |
– |
– |
Cost of Revenue |
– |
– |
– |
– |
|
Gross Profit |
– |
– |
– |
– |
|
|
Operating Expenses |
|
Research Development |
– |
– |
– |
– |
|
Selling General and Administrative |
678 |
1,780 |
1,495 |
131 |
|
Non Recurring |
– |
– |
– |
– |
|
Others |
– |
– |
– |
– |
|
|
|
Total Operating Expenses |
– |
– |
– |
– |
|
|
Operating Income or Loss |
(678) |
(1,780) |
(1,495) |
(131) |
|
|
Income from Continuing Operations |
|
Total Other Income/Expenses Net |
(0) |
0 |
0 |
(559) |
|
Earnings Before Interest And Taxes |
(678) |
(1,780) |
(1,495) |
(132) |
|
Interest Expense |
– |
– |
– |
14 |
|
Income Before Tax |
(678) |
(1,780) |
(1,495) |
(146) |
|
Income Tax Expense |
– |
– |
– |
– |
|
Minority Interest |
56 |
110 |
50 |
– |
|
|
|
Net Income From Continuing Ops |
(622) |
(1,670) |
(1,445) |
(705) |
|
|
Non-recurring Events |
|
Discontinued Operations |
– |
– |
– |
– |
|
Extraordinary Items |
– |
– |
– |
– |
|
Effect Of Accounting Changes |
– |
– |
– |
– |
|
Other Items |
– |
– |
– |
– |
|
|
Net Income |
(622) |
(1,670) |
(1,445) |
(705) |
Preferred Stock And Other Adjustments |
– |
– |
– |
– |
|
Net Income Applicable To Common Shares |
(622) |
(1,670) |
(1,445) |
(705) |
|